Patent waivers alone may not lead to quick vaccine access: Experts
New Delhi, May 8 -- The waiving off of patents alone is unlikely to help improve vaccine availability anytime soon, scientists, legal experts and pharma industry executives said, pointing to the complicated technical know-how, raw materials and infrastructure required to make vaccines while ensuring they are as safe and effective as the original developer intended it to be....
To read the full article or to get the complete feed from this publication, please
Contact Us.